Abstract: There is provided a fast dissolving solid dosage form adapted for the release of a biologically active material in the oral cavity wherein the dosage form comprises at least one biologically active material, and at least one matrix forming agent, wherein the dosage form substantially dissolves in the oral cavity. A method of producing the same and a kit comprising the same are also provided.

Abstract: The invention provides a making method of modified polyvinyl alcohol embolic microspheres. First, polyvinyl alcohol dimethyl sulfoxide solution is added to acryloyl chloride dichloromethane solution for reaction, then taurine solution is added to the above solution for further reaction, so that functional groups are introduced into the side chains of polyvinyl alcohol, then blank microspheres are prepared by suspension crosslinking method, and finally, drug-loaded modified polyvinyl alcohol embolic microspheres are prepared. The invention aims at improving the drug loading rate and drug loading speed of the microspheres. Through modification, the crystallinity of polyvinyl alcohol is weakened, the swelling in water is accelerated, and the application effect of the microspheres is improved.

Abstract: A submicron structure comprising a silica body defining a plurality of pores that are suitable to receive molecules therein, and having a surface, and a phospholipid bilayer coating the surface, wherein said submicron structure has a maximum dimension of less than one micron, and wherein the phospholipid bilayer stably seals the plurality of pores; and wherein the submicron structure is a member of a monodisperse population of submicron structures.

Abstract: A composition for improved oral care includes fibrillated material and friction elements for removal of plaque biofilm, and additional ingredients useful in oral care compositions. The composition also may include particulate SuperAbsorbent Polymer, which may be surface cross-linked. Certain ingredients may be minimized or avoided to reduce the lubricity of the composition. The composition may be a viscoelastic fluid having a desired viscosity, yield stress and elastic modulus. The efficacy can be characterized by its removal of biofilm due to flow inside tubes. Also useful are standard rheological and tribological measurements. Also disclosed are apparatus for administering the composition, and methods.

Abstract: Disclosed is use of 5?-androst-3?,5,6?-triol or an analogue, a deuterated compound or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for the treatment of cerebral small vessel disease in a patient. The cerebral small vessel disease is preferably cerebral microbleed. The cerebral microbleed is spontaneous cerebral microbleed, drug-related cerebral microbleed, or traumatic cerebral microbleed. The present invention demonstrates that these compounds significantly enhance the clearance of extravascular hemoglobin, and thus can be used to treat cerebral small vessel disease.

Abstract: The present invention is in the field of rinse-off conditioner compositions; in particular, relates to rinse-off conditioner compositions for hair frizz reduction. Deposition of conditioning materials onto the hair surface results in hair having a greasy feel and look which is undesired. Therefore, there still exists the opportunity to increase the conditioning benefits delivered through hair care compositions, preferably without hair having to look and feel greasy. It is therefore the object of the present invention to provide a conditioning product with superior frizz control even after multiple washes and which does not make the hair look and feel greasy. It has been found that a conditioner composition providing superior frizz control can be obtained using a specific combination of silicones and a tricarboxylic acid.

Abstract: Disclosed are oral care compositions comprising a thickening silica and a fluoride ion source, wherein fluoride is absorbed on the thickening silica and wherein the pH of the composition is below 5.5, as well as to methods of using these compositions. The thickening silica may have a particle size distribution (D95) less than or equal to 7 ?m and a BET surface area of greater than or equal to 150 m2/g.

Abstract: An object of the present invention is to provide an asenapine-containing patch having excellent adhesiveness and handleability, which can persistently provide sufficient medicinal effects by suppressing cold flow during storage or application while enhancing skin permeability using a silicone-based pressure-sensitive adhesive base, and thereby maintaining the stability of the drug in the patch during storage, and maintaining an appropriate administration form for a long period of time. The present invention relates to a patch having a support and a pressure-sensitive adhesive layer, wherein the pressure-sensitive adhesive layer comprises asenapine and a silicone-based pressure-sensitive adhesive base, and the loss tangent (tan ?) of the pressure-sensitive adhesive layer is 0.75 to 1.5 at 1.0 Hz.

Abstract: The present disclosure provides a water in oil type cosmetic composition that prevents syneresis and exhibits favorable stability. A water in oil type cosmetic composition for preventing syneresis of the present disclosure is characterized by containing a compound which is solubilized by being neutralized as an active component. In addition, a preferred embodiment of the water in oil type cosmetic composition for preventing syneresis of the present disclosure is characterized by the compound which is solubilized by being neutralized being a water soluble compound which has a sulfonic acid group. Further, a water in oil type cosmetic of the present disclosure is characterized by containing: a compound which is solubilized by being neutralized; a gelling agent; water; and a powder component; the viscosity of the water in oil cosmetic being greater than or equal to 7000 mPa·s.

Abstract: The present invention includes: 1) dissolving a first binder in a first solvent; 2) dissolving a dispersing agent in a solution in which the first binder is dissolved; 3) adding charcoal powder to the solution obtained in 2) and performing homogenous mixing to produce a dispersion in which the charcoal powder is bound to the first binder; 4) spray drying the dispersion obtained in 3) to produce a primary capsule from which the first solvent is removed; 5) dissolving a second binder and a softening agent in a second solvent; 6) homogeneously mixing a coloring agent and the dispersing agent with a solution in which the second binder and the softening agent are dissolved; 7) mixing the primary capsule with the solution obtained in 6) to produce a double capsule dispersion in which the primary capsule is bound to the second binder; and 8) spray-drying the double capsule dispersion to product a double capsule from which the second solvent is removed.

Abstract: Provided is an adhesive gel nail which includes a base film, an adhesive layer on the base film, a printed layer on the adhesive layer, an UV gel coating layer on the printed layer, an LED gel coating layer on the UV gel coating layer, and a highpoint glossy-top coating layer on the LED gel coating layer, and the highpoint glossy-top coating layer is formed by applying and drying a glossy-top coating solution in which a monomer, an oligomer, a cellulose, and a long-wavelength initiator are mixed.

Abstract: Dentifrice compositions comprising zinc ion, glycine and fluoride ion source, especially in the absence of stannous ion source, are provided for treating dental plaque biofilm.

Abstract: A composition includes a microemulsion. The microemulsion includes an aqueous phase, an oil phase, and a surface-active agent. The aqueous phase includes water and at least one polyol. The oil phase includes a therapeutically effective amount of tolnaftate and a carrier including Jojoba oil. The microemulsion includes a disperse phase having a particle size of 50 nm or less. A method for making a composition includes forming a first mixture by combining water and at least one polyol; forming a second mixture by combining Jojoba oil, a surface-active agent, and a therapeutically effective amount of tolnaftate; and combining and mixing the first mixture and the second mixture to form a microemulsion. A method of using a composition includes applying the composition to a site of treatment.

Abstract: An aqueous oral care one-part composition (e.g., solution), a kit that includes such composition (e.g., solution), and methods (e.g., a method of providing fluoride to a patient's tooth surface), wherein the oral care composition (e.g., solution) includes: silver cations; iodide anions; fluoride anions; and water.

Abstract: Estrogen and progesterone replacement therapies are provided herein. Among others, the following formulations are provided herein: solubilized estradiol without progesterone; micronized progesterone without estradiol; micronized progesterone with partially solubilized progesterone; solubilized estradiol with micronized progesterone; solubilized estradiol with micronized progesterone in combination with partially solubilized progesterone; and solubilized estradiol with solubilized progesterone.

Abstract: The present invention provides a liposomal topical formulation or a liposomal topical formulation base having barrier-forming siliconic components, methods for making the same, and methods for using the same in the treatment of dermatological diseases and conditions, including male pattern baldness.

Abstract: The invention discloses transparent cleansing compositions for personal care which are based on one or more vegetable oils, potassium N-acyl L-prolinate as an anionic surfactant and polyglyceryl-3 oleate as a non-ionic surfactant. The personal care cleansing formulae disclosed herein are totally based on bio-renewable ingredients. Further, in contrast to the compositions from the prior arts, the cleansing compositions of the present invention are free from toxic and petrochemical based ingredients or impurities.

Abstract: The present disclosure relates to a pumping type toothpaste composition capable of being provided as contained in a pumping type container, and relates to a pumping type transparent toothpaste composition comprising or not comprising an abrasive. The pumping type toothpaste composition of the present disclosure has excellent commercial value due to its transparent formulation.

Abstract: A make-up emulsion composition includes an aqueous internal phase emulsified in an external fatty phase. The fatty phase includes at least one silicone oil, silicone resin, silica aerogel, spherical silica, clay, starch, pigment, and emulsifier. Methods of use are also provided.

Abstract: The present disclosure is directed to injectable formulations that include biodegradable polymers based on trimethylene carbonate (TMC) with mole fractions of polylactic acid (PLA) and/or polyglycolic acid (PGA) that are used to deliver a bioactive agent to a targeted site. Excipients such as polyethylene glycol (PEG) may be added to the formulations to reduce the injection force and/or to modulate the release of the bioactive agent. Suitable biodegradable polymers for use in the injectable formulations include D,L-PLA:TMC, D-PLA:TMC, L-PLA:TMC, TMC:PLA:PGA and variations thereof. Additionally, copolymers of TMC and PLA and terpolymers of TMC:PLA:PGA may be formed into nanoparticles and delivered to the target site with an injectable crosslinkable polyethylene glycol system. In at least one embodiment, the injectable formulations are used to treat ocular diseases.